Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04272619 · ClinicalTrials.gov registry record · NA
Liver Cancer Community Education
A NA study, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT04272619 is a NA study that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 67 participants.
The verdict
NCT04272619, a NA study, has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
This study proposes to bridge the gap between evidence and action and combat rising liver cancer rates attributed to Hepatitis B and C infection in Philadelphia by identifying neighborhoods with higher than expected rates of liver cancer and related risk factors and administering an educational intervention about liver cancer and neighborhood health in those communities, working with existing community partners at Fox Chase Cancer Center.
Interventions
- BEHAVIORAL LIVE-R Life Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2020-02-11 |
| Est. Completion | 2023-04-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04272619
The ClinicalTrials.gov registry entry for NCT04272619 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LIVE-R Life Education is the first listed.
NCT04272619 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04272619 about?
NCT04272619 is a clinical study titled "Liver Cancer Community Education". This study proposes to bridge the gap between evidence and action and combat rising liver cancer rates attributed to Hepatitis B and C infection in Philadelphia by identifying neighborhoods with higher than expected rates of liver cancer and related risk factors and administering an educational inte...
What is the current status of trial NCT04272619?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2020-02-11. Estimated completion is 2023-04-06.
What interventions are being tested in trial NCT04272619?
The interventions under investigation include: LIVE-R Life Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT04272619?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.